Download video

Dipyridamole, PDE3 inhibitor, antiplatelet, vasodilation, stroke prevention, peripheral artery

16K views

ROZE PHARM

4 years ago

Dipyridamole, PDE3 inhibitor, antiplatelet, vasodilation, stroke prevention, peripheral artery

Dipyridamole, PDE3 inhibitor, antiplatelet, vasodilation, stroke prevention, peripheral artery

PDE3 Inhibitors (Cilostazol, Dipyridamole) Mnemonic for USMLE
1:46
PDE3 Inhibitors (Cilostazol, Dipyridamole) Mnemonic for USMLE
by Pixorize
Antiplatelet drugs - aspirin, clopidogrel, dipyridamole, mechanism of action, adverse drug reactions
1:46
Antiplatelet drugs - aspirin, clopidogrel, dipyridamole, mechanism of action, adverse drug reactions
by Medic Notes
Dipyridamole: How a Drug for Blood Clots Became a New Treatment for Restless Legs Syndrome (RLS)
7:11
Dipyridamole: How a Drug for Blood Clots Became a New Treatment for Restless Legs Syndrome (RLS)
by Andy Berkowski, MD
Aggrenox or Dipyridamole \& Aspirin Information (dosing, side effects, patient counseling)
2:25
Aggrenox or Dipyridamole \& Aspirin Information (dosing, side effects, patient counseling)
by RxLearn
Pharmacology of Dipyridamole (Persantine); Overview, Pharmacokinetics, Mechanism of action, Effects
6:16
Pharmacology of Dipyridamole (Persantine); Overview, Pharmacokinetics, Mechanism of action, Effects
by MBBS NAIJA
Antiplatelet drugs in brief
8:39
Antiplatelet drugs in brief
by DR.TARUN LAKHNOTRA
Hemostasis: Lesson 5 - Antiplatelet Meds (Part 2 of 2)
11:38
Hemostasis: Lesson 5 - Antiplatelet Meds (Part 2 of 2)
by Strong Medicine
Duloxetine Drug Information
2:00
Duloxetine Drug Information
by Veeprho Group
MDM2 Inhibitor Shows Promise For Patients With AML
1:25
MDM2 Inhibitor Shows Promise For Patients With AML
by curetoday
Celecoxib (Celebrex) and other COX-2 Selective Inhibitors
5:12
Celecoxib (Celebrex) and other COX-2 Selective Inhibitors
by Professor Dave Explains
Pharmacology - NSAIDs \& PROSTAGLANDIN ANALOGS (MADE EASY)
11:01
Pharmacology - NSAIDs \& PROSTAGLANDIN ANALOGS (MADE EASY)
by Speed Pharmacology
Balancing the Risks and Benefits of Dual Platelet Inhibition
12:12
Balancing the Risks and Benefits of Dual Platelet Inhibition
by Domenica Briones
P2Y12 Receptor Inhibitors
18:07
P2Y12 Receptor Inhibitors
by Medicosis Perfectionalis
CLARITY: a Phase 2 trial using venetoclax and ibrutinib
1:00
CLARITY: a Phase 2 trial using venetoclax and ibrutinib
by VJHemOnc – Video Journal of Hematology \& HemOnc
NSAIDs (Ibuprofen) and selective COX-2 inhibitors (Celecoxib)
11:32
NSAIDs (Ibuprofen) and selective COX-2 inhibitors (Celecoxib)
by Pharmacology Animation
FDA Approves Treatment for Transthyretin Amyloid Cardiomyopathy
8:36
FDA Approves Treatment for Transthyretin Amyloid Cardiomyopathy
by CheckRare